Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

10.24
Delayed Data
As of 2:12pm ET
 +0.07 / +0.69%
Today’s Change
8.14
Today|||52-Week Range
12.76
-1.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues32.3M41.7M51.2M47.5M
 
 
 
 
 
Cost of Goods Sold2.7M2.5M3.5M4.5M
 
 
 
 
 
Depreciation And Amortization3.9M2.8M816.6K793.5K
 
 
 
 
 
 
Operating ExpensesGross Income25.7M36.3M46.9M42.2M
 
 
 
 
 
General Expenses21.0M23.4M18.6M19.7M
 
 
 
 
 
Research And Development8.2M13.0M7.0M7.0M
 
 
 
 
 
Total Operating Expenses27.6M28.7M22.9M25.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income4.7M12.9M28.3M22.5M
 
 
 
 
 
Extraordinary Credit0.003.6M6.8M13.6M
 
 
 
 
Extraordinary Charge-21.0M0.00-2.6M-1.1M
 
 
 
 
Interest Expense On Debt265.8K252.4K256.6K269.6K
 
 
 
 
 
Other Expenses-2.9M1.2M1.3M2.5M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-19.0M17.5M33.6M37.2M
 
 
 
 
 
Income Taxes-3.5M-12.9M-8.3M-7.6M
 
 
 
 
 
Net Income-22.5M4.6M25.3M29.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS41.2M41.3M41.4M41.1M
 
 
 
 
 
Shares To Calculate EPS Diluted41.2M42.8M42.8M42.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.54$0.11$0.61$0.72
 
 
 
 
 
EPS Diluted-$0.54$0.11$0.60$0.70